Log in

NASDAQ:PRTOProteon Therapeutics Earnings Date, Estimates & History

-0.63 (-2.54 %)
(As of 08/12/2020 04:00 PM ET)
Today's Range
Now: $24.19
50-Day Range
MA: $27.55
52-Week Range
Now: $24.19
Volume13,446 shs
Average Volume1.11 million shs
Market Capitalization$536.51 million
P/E RatioN/A
Dividend YieldN/A


Proteon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 29th, 2020 based off prior year's report dates.

Proteon Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Proteon Therapeutics (NASDAQ:PRTO) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.78 EPS
Next Year EPS Consensus Estimate: $-0.34 EPS

Proteon Therapeutics (NASDAQ PRTO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/7/2019Q2 2019($0.06)($0.27)($0.27)N/A
8/7/2018Q2 2018($0.36)($0.28)($0.28)N/A
5/9/2018Q1 2018($0.37)($0.34)($0.34)N/A
3/14/2018Q4 2017($0.45)($0.31)($0.31)N/A
11/7/2017Q3 2017($0.40)($1.08)($1.08)N/A
8/7/2017Q2 2017($0.4370)($0.33)($0.33)N/A
5/10/2017Q1 2017($0.4260)($0.39)($0.39)N/A
3/16/2017Q4 2016($0.43)($0.42)($0.42)N/A
11/7/2016Q3 2016($0.46)($0.43)($0.43)N/A
8/8/2016Q2 2016($0.42)($0.48)($0.48)N/A
5/9/2016Q1 2016($0.40)($0.40)($0.40)N/A
3/14/2016Q4 2015($0.35)($0.39)($0.39)N/A
11/12/2015Q3 2015($0.34)($0.33)($0.33)N/A
8/13/2015Q2 2015($0.30)($0.31)($0.31)N/A
5/13/2015Q1 2015($0.24)($0.28)($0.28)N/A
3/20/2015Q4 2014($0.32)$0.48$0.48N/A
11/25/2014Q3 2014($0.31)($31.03)($31.03)$2.95 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.